83.00
price up icon1.23%   1.01
pre-market  Pre-market:  82.88   -0.12   -0.14%
loading
Dexcom Inc stock is traded at $83.00, with a volume of 3.44M. It is up +1.23% in the last 24 hours and down -2.90% over the past month. Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
See More
Previous Close:
$81.99
Open:
$82.8
24h Volume:
3.44M
Relative Volume:
0.88
Market Cap:
$33.60B
Revenue:
$4.15B
Net Income/Loss:
$535.20M
P/E Ratio:
61.94
EPS:
1.34
Net Cash Flow:
$575.20M
1W Performance:
-3.13%
1M Performance:
-2.90%
6M Performance:
+8.62%
1Y Performance:
-28.42%
1-Day Range:
Value
$82.27
$83.70
1-Week Range:
Value
$81.39
$86.45
52-Week Range:
Value
$57.52
$117.91

Dexcom Inc Stock (DXCM) Company Profile

Name
Name
Dexcom Inc
Name
Phone
(858) 200-0200
Name
Address
6340 SEQUENCE DRIVE, SAN DIEGO, CA
Name
Employee
10,300
Name
Twitter
@dexcom
Name
Next Earnings Date
2024-10-24
Name
Latest SEC Filings
Name
DXCM's Discussions on Twitter

Compare DXCM with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Devices icon
DXCM
Dexcom Inc
83.00 33.60B 4.15B 535.20M 575.20M 1.34
Medical Devices icon
ABT
Abbott Laboratories
134.01 232.09B 42.34B 13.50B 6.66B 7.71
Medical Devices icon
BSX
Boston Scientific Corp
101.49 148.00B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
377.12 146.09B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
87.92 112.11B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
74.82 44.79B 5.54B 4.18B 623.10M 7.00

Dexcom Inc Stock (DXCM) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-16-25 Initiated Truist Buy
May-30-25 Initiated Goldman Buy
Apr-10-25 Initiated Mizuho Outperform
Feb-03-25 Upgrade Redburn Atlantic Neutral → Buy
Jan-16-25 Upgrade Robert W. Baird Neutral → Outperform
Jul-26-24 Downgrade JP Morgan Overweight → Neutral
Jul-26-24 Downgrade Robert W. Baird Outperform → Neutral
May-30-24 Initiated Redburn Atlantic Neutral
Mar-12-24 Initiated RBC Capital Mkts Outperform
May-30-23 Resumed Morgan Stanley Equal-Weight
Apr-17-23 Upgrade Raymond James Outperform → Strong Buy
Mar-29-23 Initiated UBS Buy
Jan-26-23 Initiated Wolfe Research Outperform
Oct-18-22 Initiated Barclays Equal Weight
Oct-12-22 Initiated Jefferies Buy
Jul-15-22 Initiated Bernstein Outperform
Mar-02-22 Resumed BofA Securities Buy
Feb-03-22 Upgrade BTIG Research Neutral → Buy
Jan-19-22 Upgrade Wells Fargo Equal Weight → Overweight
Jan-07-22 Upgrade Guggenheim Neutral → Buy
Oct-18-21 Downgrade Guggenheim Buy → Neutral
Jul-21-21 Resumed Cowen Outperform
May-28-21 Upgrade Wells Fargo Underweight → Equal Weight
May-25-21 Initiated Barclays Overweight
Apr-15-21 Initiated Atlantic Equities Overweight
Jan-06-21 Upgrade UBS Neutral → Buy
Oct-02-20 Downgrade Wells Fargo Equal Weight → Underweight
May-27-20 Reiterated Piper Sandler Overweight
May-14-20 Initiated Wells Fargo Equal Weight
Mar-05-20 Initiated Citigroup Buy
Nov-07-19 Reiterated Canaccord Genuity Buy
Nov-07-19 Upgrade Guggenheim Neutral → Buy
Oct-23-19 Initiated Stifel Buy
Nov-28-18 Initiated UBS Neutral
Oct-19-18 Upgrade Goldman Sell → Neutral
Sep-12-18 Upgrade Northland Capital Under Perform → Market Perform
Aug-02-18 Reiterated Canaccord Genuity Buy
Jul-02-18 Upgrade Raymond James Mkt Perform → Outperform
Jun-08-18 Upgrade JP Morgan Neutral → Overweight
May-11-18 Initiated BofA/Merrill Buy
May-03-18 Reiterated Canaccord Genuity Buy
Apr-04-18 Initiated Goldman Sell
Apr-04-18 Initiated Guggenheim Neutral
Mar-23-18 Upgrade Robert W. Baird Neutral → Outperform
Jan-04-18 Downgrade Northland Capital Market Perform → Under Perform
Sep-28-17 Reiterated Wedbush Outperform
View All

Dexcom Inc Stock (DXCM) Latest News

pulisher
02:44 AM

DexCom’s SWOT analysis: CGM leader’s stock poised for growth amid challenges - Investing.com

02:44 AM
pulisher
02:36 AM

DexCom's SWOT analysis: CGM leader's stock poised for growth amid challenges - Investing.com

02:36 AM
pulisher
Jun 16, 2025

Expert Outlook: DexCom Through The Eyes Of 8 Analysts - Nasdaq

Jun 16, 2025
pulisher
Jun 16, 2025

DexCom (DXCM) Receives 'Buy' Rating from Truist Securities with $102 Price Target | DXCM Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

DexCom (DXCM) Gains Analysts' Favor Despite Past Challenges - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

DexCom Stock: Is DXCM Underperforming The Health Care Sector? - Barchart.com

Jun 16, 2025
pulisher
Jun 16, 2025

DexCom Stock: Is DXCM Underperforming the Health Care Sector? - The Globe and Mail

Jun 16, 2025
pulisher
Jun 16, 2025

DexCom (DXCM) Receives Buy Rating Amid Promising Market Prospects | DXCM Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Truist Initiates DexCom at Buy With $102 Price Target - marketscreener.com

Jun 16, 2025
pulisher
Jun 16, 2025

DexCom Insiders Sell US$11m Of Stock, Possibly Signalling Caution - simplywall.st

Jun 16, 2025
pulisher
Jun 10, 2025

Johnson Fistel Continues Investigation on Behalf of DexCom, Inc. Shareholders - Business Wire

Jun 10, 2025
pulisher
Jun 10, 2025

Insulet rolls out new Omnipod 5 iPhone app for use with Dexcom G7 - MassDevice

Jun 10, 2025
pulisher
Jun 10, 2025

Insulet Corporation's Omnipod 5 App for Iphone with Dexcom G7 Integration Now Available to All U.S. Users - marketscreener.com

Jun 10, 2025
pulisher
Jun 10, 2025

Insulet Releases Omnipod 5 App for iPhone with Dexcom G7 CGM in U.S. - Medical Product Outsourcing

Jun 10, 2025
pulisher
Jun 10, 2025

Diabetes partnerships abound ahead of ADA - BioWorld MedTech

Jun 10, 2025
pulisher
Jun 10, 2025

Insulet's Omnipod® 5 App For iPhone With Dexcom G7 Integration Now Available To All US Users - marketscreener.com

Jun 10, 2025
pulisher
Jun 10, 2025

Insulet (PODD) Omnipod 5 App Now Compatible with Dexcom G7 on iPhone | PODD Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Insulet's Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users | PODD Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Insulet’s Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users - Business Wire

Jun 10, 2025
pulisher
Jun 09, 2025

DexCom, Inc. (DXCM) Stock Analysis: Analyst Consensus Points to 13.59% Potential Upside - DirectorsTalk Interviews

Jun 09, 2025
pulisher
Jun 08, 2025

DexCom (NASDAQ:DXCM) Stock Rating Upgraded by Wall Street Zen - Defense World

Jun 08, 2025
pulisher
Jun 07, 2025

DexCom, Inc. (NASDAQ:DXCM) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World

Jun 07, 2025
pulisher
Jun 05, 2025

Johnson Fistel has Commenced an Investigation on Behalf of DexCom, Inc. Shareholders - GlobeNewswire

Jun 05, 2025
pulisher
Jun 04, 2025

BGM and CGM Market is Set to Experience a Revolutionary Growth | Abbott Laboratories , Dexcom, Medtronic PLC - openPR.com

Jun 04, 2025
pulisher
Jun 02, 2025

Goldman Sachs Bullish On Dexcom And Insulet As Diabetes Tech Surges - Benzinga

Jun 02, 2025
pulisher
Jun 02, 2025

Should You Be Excited About DexCom, Inc.'s (NASDAQ:DXCM) 24% Return On Equity? - simplywall.st

Jun 02, 2025
pulisher
Jun 01, 2025

Goldman Sachs Initiates Coverage of DexCom (XTRA:DC4) with Buy Recommendation - Nasdaq

Jun 01, 2025
pulisher
May 31, 2025

Goldman Sachs Initiates Coverage of DexCom (BIT:1DXCM) with Buy Recommendation - Nasdaq

May 31, 2025
pulisher
May 31, 2025

DexCom (NASDAQ:DXCM) Now Covered by Analysts at The Goldman Sachs Group - Defense World

May 31, 2025
pulisher
May 30, 2025

Goldman Sachs Initiates Coverage of DexCom (DXCM) with Buy Recommendation - Nasdaq

May 30, 2025
pulisher
May 30, 2025

Goldman Sachs Initiates Coverage of DexCom (DXCM) With Buy Rating - MSN

May 30, 2025
pulisher
May 30, 2025

Forecasting The Future: 7 Analyst Projections For DexCom - Benzinga

May 30, 2025
pulisher
May 30, 2025

DexCom, Inc. (NASDAQ:DXCM) Q2 2024 Earnings Call Transcript - MSN

May 30, 2025
pulisher
May 30, 2025

Jefferies Adjusts Price Target on DexCom to $110 From $105, Maintains Buy Rating - marketscreener.com

May 30, 2025
pulisher
May 30, 2025

Goldman Sachs Initiates DexCom at Buy With $104 Price Target - marketscreener.com

May 30, 2025
pulisher
May 29, 2025

DexCom (DXCM) Receives Positive Coverage with Growth Potential | - GuruFocus

May 29, 2025
pulisher
May 29, 2025

DexCom (DXCM) Receives Positive Coverage with Growth Potential | DXCM Stock News - GuruFocus

May 29, 2025
pulisher
May 28, 2025

Dexcom’s EVP Sadie Stern sells $526,318 in shares - Investing.com

May 28, 2025
pulisher
May 27, 2025

GlucoGuard a Division of American Diversified Holdings (ADHC) Successfully Submits Level 2 App Integration Through Dexcom's Developer Partner Program - The Globe and Mail

May 27, 2025
pulisher
May 26, 2025

DexCom, Inc. (DXCM) Stock Analysis: 15.97% Potential Upside Amid Robust Analyst Support - DirectorsTalk Interviews

May 26, 2025
pulisher
May 24, 2025

DexCom’s SWOT analysis: CGM leader faces supply challenges amid growth - Investing.com

May 24, 2025
pulisher
May 23, 2025

DexCom: Non-Insulin Type 2 Diabetes Market Penetration Be A Breakthrough Move? - Smartkarma

May 23, 2025
pulisher
May 23, 2025

An Intrinsic Calculation For DexCom, Inc. (NASDAQ:DXCM) Suggests It's 27% Undervalued - Yahoo Finance

May 23, 2025
pulisher
May 23, 2025

Blood Glucose Monitoring (BGM) Devices Market Report 2025: Hospitals Lead in Blood Glucose Monitoring Device Usage, Home Care Grows Fastest - GlobeNewswire Inc.

May 23, 2025
pulisher
May 22, 2025

DexCom (DXCM) Maintains Buy Rating as Price Target Raised to USD 102 | DXCM Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Citi Increases Price Target for DexCom (DXCM) to $102 | DXCM Sto - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Citi Increases Price Target for DexCom (DXCM) to $102 | DXCM Stock News - GuruFocus

May 22, 2025
pulisher
May 21, 2025

Diabetic Care Device Market Set for Significant Growth with 10.1% CAGR - GlobeNewswire Inc.

May 21, 2025
pulisher
May 21, 2025

Dexcom (DXCM) Gets a Buy from Wells Fargo - The Globe and Mail

May 21, 2025
pulisher
May 21, 2025

DexCom adds Renée Galá to Board of Directors By Investing.com - Investing.com Nigeria

May 21, 2025
pulisher
May 20, 2025

3 Big Reasons to Love DexCom (DXCM) - Yahoo Finance

May 20, 2025

Dexcom Inc Stock (DXCM) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$72.86
price up icon 0.84%
medical_devices STE
$241.16
price down icon 0.07%
medical_devices EW
$74.82
price down icon 0.44%
medical_devices PHG
$22.84
price up icon 0.40%
$306.59
price up icon 0.64%
Cap:     |  Volume (24h):